Andrographolide Inhibits Lytic Reactivation of Epstein-Barr Virus by Modulating Transcription Factors in Gastric Cancer

Andrographolide is the principal bioactive chemical constituent of <i>Andrographis paniculata</i> and exhibits activity against several viruses, including Epstein–Barr virus (EBV). However, the particular mechanism by which andrographolide exerts an anti-EBV effect in EBV-associated gast...

Full description

Bibliographic Details
Main Authors: Praphatson Malat, Tipaya Ekalaksananan, Chukkris Heawchaiyaphum, Supawadee Suebsasana, Sittiruk Roytrakul, Yodying Yingchutrakul, Chamsai Pientong
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Microorganisms
Subjects:
Online Access:https://www.mdpi.com/2076-2607/9/12/2561
_version_ 1827671016962260992
author Praphatson Malat
Tipaya Ekalaksananan
Chukkris Heawchaiyaphum
Supawadee Suebsasana
Sittiruk Roytrakul
Yodying Yingchutrakul
Chamsai Pientong
author_facet Praphatson Malat
Tipaya Ekalaksananan
Chukkris Heawchaiyaphum
Supawadee Suebsasana
Sittiruk Roytrakul
Yodying Yingchutrakul
Chamsai Pientong
author_sort Praphatson Malat
collection DOAJ
description Andrographolide is the principal bioactive chemical constituent of <i>Andrographis paniculata</i> and exhibits activity against several viruses, including Epstein–Barr virus (EBV). However, the particular mechanism by which andrographolide exerts an anti-EBV effect in EBV-associated gastric cancer (EBVaGC) cells remains unclear. We investigated the molecular mechanism by which andrographolide inhibits lytic reactivation of EBV in EBVaGC cells (AGS-EBV cell line) using proteomics and bioinformatics approaches. An andrographolide treatment altered EBV protein-expression patterns in AGS-EBV cells by suppressing the expression of EBV lytic protein. Interestingly cellular transcription factors (TFs), activators for EBV lytic reactivation, such as MEF2D and SP1, were significantly abolished in AGS-EBV cells treated with andrographolide and sodium butyrate (NaB) compared with NaB-treated cells. In contrast, the suppressors of EBV lytic reactivation, such as EZH2 and HDAC6, were significantly up-regulated in cells treated with both andrographolide and NaB compared with NaB treatment alone. In addition, bioinformatics predicted that HDAC6 could interact directly with MEF2D and SP1. Furthermore, andrographolide significantly induced cell cytotoxicity and apoptosis of AGS-EBV cells by induction of apoptosis-related protein expression. Our results suggest that andrographolide inhibits EBV lytic reactivation by inhibition of host TFs, partially through the interaction of HDAC6 with TFs, and induces apoptosis of EBVaGC cells.
first_indexed 2024-03-10T03:31:16Z
format Article
id doaj.art-556c19201a7540739e2923c3bb743c90
institution Directory Open Access Journal
issn 2076-2607
language English
last_indexed 2024-03-10T03:31:16Z
publishDate 2021-12-01
publisher MDPI AG
record_format Article
series Microorganisms
spelling doaj.art-556c19201a7540739e2923c3bb743c902023-11-23T09:39:53ZengMDPI AGMicroorganisms2076-26072021-12-01912256110.3390/microorganisms9122561Andrographolide Inhibits Lytic Reactivation of Epstein-Barr Virus by Modulating Transcription Factors in Gastric CancerPraphatson Malat0Tipaya Ekalaksananan1Chukkris Heawchaiyaphum2Supawadee Suebsasana3Sittiruk Roytrakul4Yodying Yingchutrakul5Chamsai Pientong6Department of Microbiology, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, ThailandDepartment of Microbiology, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, ThailandDepartment of Microbiology, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, ThailandDepartment of Pharmaceutical Sciences, Faculty of Pharmacy, Thammasat University, Bangkok 10200, ThailandGenome Technology Research Unit, Proteomics Research Laboratory, National Center for Genetic Engineering and Biotechnology (BIOTEC), Pathum Thani 12120, ThailandGenome Technology Research Unit, Proteomics Research Laboratory, National Center for Genetic Engineering and Biotechnology (BIOTEC), Pathum Thani 12120, ThailandDepartment of Microbiology, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, ThailandAndrographolide is the principal bioactive chemical constituent of <i>Andrographis paniculata</i> and exhibits activity against several viruses, including Epstein–Barr virus (EBV). However, the particular mechanism by which andrographolide exerts an anti-EBV effect in EBV-associated gastric cancer (EBVaGC) cells remains unclear. We investigated the molecular mechanism by which andrographolide inhibits lytic reactivation of EBV in EBVaGC cells (AGS-EBV cell line) using proteomics and bioinformatics approaches. An andrographolide treatment altered EBV protein-expression patterns in AGS-EBV cells by suppressing the expression of EBV lytic protein. Interestingly cellular transcription factors (TFs), activators for EBV lytic reactivation, such as MEF2D and SP1, were significantly abolished in AGS-EBV cells treated with andrographolide and sodium butyrate (NaB) compared with NaB-treated cells. In contrast, the suppressors of EBV lytic reactivation, such as EZH2 and HDAC6, were significantly up-regulated in cells treated with both andrographolide and NaB compared with NaB treatment alone. In addition, bioinformatics predicted that HDAC6 could interact directly with MEF2D and SP1. Furthermore, andrographolide significantly induced cell cytotoxicity and apoptosis of AGS-EBV cells by induction of apoptosis-related protein expression. Our results suggest that andrographolide inhibits EBV lytic reactivation by inhibition of host TFs, partially through the interaction of HDAC6 with TFs, and induces apoptosis of EBVaGC cells.https://www.mdpi.com/2076-2607/9/12/2561andrographolideEBVEBV lytic reactivationtranscriptional factorMEF2DSP1
spellingShingle Praphatson Malat
Tipaya Ekalaksananan
Chukkris Heawchaiyaphum
Supawadee Suebsasana
Sittiruk Roytrakul
Yodying Yingchutrakul
Chamsai Pientong
Andrographolide Inhibits Lytic Reactivation of Epstein-Barr Virus by Modulating Transcription Factors in Gastric Cancer
Microorganisms
andrographolide
EBV
EBV lytic reactivation
transcriptional factor
MEF2D
SP1
title Andrographolide Inhibits Lytic Reactivation of Epstein-Barr Virus by Modulating Transcription Factors in Gastric Cancer
title_full Andrographolide Inhibits Lytic Reactivation of Epstein-Barr Virus by Modulating Transcription Factors in Gastric Cancer
title_fullStr Andrographolide Inhibits Lytic Reactivation of Epstein-Barr Virus by Modulating Transcription Factors in Gastric Cancer
title_full_unstemmed Andrographolide Inhibits Lytic Reactivation of Epstein-Barr Virus by Modulating Transcription Factors in Gastric Cancer
title_short Andrographolide Inhibits Lytic Reactivation of Epstein-Barr Virus by Modulating Transcription Factors in Gastric Cancer
title_sort andrographolide inhibits lytic reactivation of epstein barr virus by modulating transcription factors in gastric cancer
topic andrographolide
EBV
EBV lytic reactivation
transcriptional factor
MEF2D
SP1
url https://www.mdpi.com/2076-2607/9/12/2561
work_keys_str_mv AT praphatsonmalat andrographolideinhibitslyticreactivationofepsteinbarrvirusbymodulatingtranscriptionfactorsingastriccancer
AT tipayaekalaksananan andrographolideinhibitslyticreactivationofepsteinbarrvirusbymodulatingtranscriptionfactorsingastriccancer
AT chukkrisheawchaiyaphum andrographolideinhibitslyticreactivationofepsteinbarrvirusbymodulatingtranscriptionfactorsingastriccancer
AT supawadeesuebsasana andrographolideinhibitslyticreactivationofepsteinbarrvirusbymodulatingtranscriptionfactorsingastriccancer
AT sittirukroytrakul andrographolideinhibitslyticreactivationofepsteinbarrvirusbymodulatingtranscriptionfactorsingastriccancer
AT yodyingyingchutrakul andrographolideinhibitslyticreactivationofepsteinbarrvirusbymodulatingtranscriptionfactorsingastriccancer
AT chamsaipientong andrographolideinhibitslyticreactivationofepsteinbarrvirusbymodulatingtranscriptionfactorsingastriccancer